Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Menu
Advanced
Wish Lists Wish Lists
Wish Lists Wish Lists
Wish Lists
Cart Cart
Cart Cart
Cart
Sign in
Sign in
Contact us
Advanced
Homepage > Company > Media > Pharma News > 2019

Pharma News, 2019

Researchers identify a new way to target treatment-resistant cancers
Researchers identify a new way to target treatment-resistant cancers
An international team of researchers has found a different way cancer becomes resistant to chemotherapy, suggesting a new target for drugs.
Biogen surges 42% after stunning reversal sees it revive plans for Alzheimer's treatment
Biogen surges 42% after stunning reversal sees it revive plans for Alzheimer's treatment
Shares of Biogen surged more than 42% on Tuesday morning after the company announced plans to seek approval for an experimental Alzheimer's treatment called aducanumab.
A new theory on depression: It’s a disease caused by the body’s immune system
A new theory on depression: It’s a disease caused by the body’s immune system
The idea that depression might be caused by a chemical imbalance in the brain – and not a moral failing – grew in popularity with the invention of the drug Prozac in the late ‘80s, and later wit...
Trump urges quicker action to allow imported drugs from Canada
Trump urges quicker action to allow imported drugs from Canada
WASHINGTON (Reuters) - U.
Alexion acquiring Achillion to expand reach into rare, immune-related disease
Alexion acquiring Achillion to expand reach into rare, immune-related disease
Alexion Pharmaceuticals (ALXN) said Wednesday that it will acquire Achillion Pharmaceuticals (ACHN) to expand its pipeline of experimental drugs targeting rare diseases of the immune s...
FDA generic drug approvals reach record high in fiscal year 2019
FDA generic drug approvals reach record high in fiscal year 2019
Statement From.
Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer
Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer
SAN DIEGO, Sept.
Israel's Healthy.io raises $60 million, gets FDA ok for urine test
Israel's Healthy.io raises $60 million, gets FDA ok for urine test
TEL AVIV (Reuters) - Israel’s Healthy.
Purdue inks multibillion-dollar opioid deal with thousands of local governments, more than 20 states: reports
Purdue inks multibillion-dollar opioid deal with thousands of local governments, more than 20 states: reports
Purdue Pharma has entered the first major opioid settlement.
New drug to protect against Alzheimer: Study
New drug to protect against Alzheimer: Study
New York.
Xeris Pharmaceuticals Receives U.S. FDA Approval for GVOKE™ (glucagon), the First Ready-to-use Stable Liquid Glucagon for Severe Hypoglycemia
Xeris Pharmaceuticals Receives U.S. FDA Approval for GVOKE™ (glucagon), the First Ready-to-use Stable Liquid Glucagon for Severe Hypoglycemia
First approval for Xeris is based on positive efficacy and safety results from multiple clinical studiesGVOKE is the first premixed, prefilled, premeasured liquid glucagon offering ease of use for ped...
Sanofi to pay Lexicon $260 million for terminated partnership
Sanofi to pay Lexicon $260 million for terminated partnership
(Reuters) - Lexicon Pharmaceuticals Inc said on Tuesday France’s Sanofi SA will pay the drugmaker $260 million for the termination of their partnership to develop diabetes drug Zynquista.
0 items in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Screening Compounds
Building blocks
Inhibitors and approved drugs
Drug Discovery Services
Custom chemistry. Chemistry FTE. Resynthesis.
Hit Follow up Support
Medicinal chemistry FTE
In silico drug design (CADD)
Discovery Biology. Biology FTE. In vitro studies.
Animal models
Toxicology and safety
ADME, DMPK. In vivo studies
Chemistry, manufacturing and controls
Company
News & Media
Contact us
Trends in discovery compounds